Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 24,750 KRW
Change Today -750.00 / -2.94%
Volume 63.7K
000230 On Other Exchanges
Symbol
Exchange
Korea SE
As of 8:34 PM 05/25/15 All times are local (Market data is delayed by at least 15 minutes).

il dong pharmaceutical co lt (000230) Snapshot

Open
25,400
Previous Close
25,500
Day High
25,400
Day Low
24,000
52 Week High
05/22/15 - 28,700
52 Week Low
06/2/14 - 13,400
Market Cap
620.4B
Average Volume 10 Days
599.7K
EPS TTM
489.00
Shares Outstanding
25.1M
EX-Date
12/29/14
P/E TM
50.6x
Dividend
200.00
Dividend Yield
0.81%
Current Stock Chart for IL DONG PHARMACEUTICAL CO LT (000230)

Related News

No related news articles were found.

il dong pharmaceutical co lt (000230) Related Businessweek News

No Related Businessweek News Found

il dong pharmaceutical co lt (000230) Details

Ildong Pharmaceutical Co., Ltd. provides various pharmaceutical products in South Korea. The company offers active lactic acid bacteria and anti-diarrheal agents, antibiotics, antifungals and antivirals, anti-histamine drugs, antineoplastic agents, NSAIDs and analgesics, topical preparations, vitamins, and mineral and nutrients; and drugs for blood circulation, cardiovascular system, central nervous system, dental treatment, endocrine and metabolic systems, gastrointestinal system, respiratory system, and urogenital system. It also provides raw material drugs, such as synthesis, probiotics, and biometabolites; health foods and foods; cosmetics; medical devices; and other products. The company also exports its products to Japan, Vietnam, Azerbaijan, Cambodia, Dominican Republic, Guatemala, Indonesia, Malaysia, Mexico, Myanmar, Pakistan, the Philippines, Singapore, Vietnam, Yemen, etc. The company was formerly known as Keukdong Pharmaceuticals Co., Ltd. and changed its name to Ildong Pharmaceutical Co., Ltd. in May 1942. The company was founded in 1941 and is headquartered in Seoul, South Korea.

Founded in 1941

il dong pharmaceutical co lt (000230) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

il dong pharmaceutical co lt (000230) Key Developments

Ildong Pharmaceutical Reports Earnings Results for the First Quarter of 2015

Ildong Pharmaceutical reported earnings results for the first quarter of 2015. For the quarter, the company posted a 31.4% year on year rise in revenue to KRW 114.9 billion. Operating profit for the quarter jumped 256% year on year to KRW 12.1 billion.

Ildong Pharmaceutical Co., Ltd., Annual General Meeting, Mar 20, 2015

Ildong Pharmaceutical Co., Ltd., Annual General Meeting, Mar 20, 2015., at 10:00 Korea Standard Time. Location: 27 way 2 Nitto Pharmaceutical headquarters auditorium. Agenda: To consider the audit report, business report, external audit report appointment; to consider financial statements and consolidated financial statements; to consider appointment of Independent candidates; to consider appointment auditor; to consider approval of remuneration ceiling bill; and to consider approval of audit fees limit.

Arena Pharmaceuticals GmbH Appoints Ildong Pharmaceutical Co., Ltd. as Distributer in South Korea

On February 3, 2015, Arena Pharmaceuticals Inc. announced that Ildong Pharmaceutical Co., Ltd., has informed that the Ministry of Food and Drug Safety has approved BELVIQ for marketing for weight management in South Korea. Ildong will market and distribute BELVIQ in South Korea under its marketing and supply agreement with wholly owned subsidiary, Arena Pharmaceuticals GmbH. In connection with the approval, the company will receive a milestone payment of $3.0 million from Ildong.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000230:KS 24,750.00 KRW -750.00

000230 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000230.
View Industry Companies
 

Industry Analysis

000230

Industry Average

Valuation 000230 Industry Range
Price/Earnings 52.0x
Price/Sales 1.5x
Price/Book 1.9x
Price/Cash Flow 43.2x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IL DONG PHARMACEUTICAL CO LT, please visit www.ildong.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.